These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 131008)

  • 1. Effect of clofibrate on plasma proteins including components of the hemostatic mechanism.
    Cederblad G; Korsan-Bengtsen K
    Clin Chim Acta; 1976 Jan; 66(1):9-17. PubMed ID: 131008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative clinical study of the effects of Na isobutyrate and clofibrate on the clotting factors in patients with atherosclerosis.
    Papilian-Stoichiţă M; Chiosa L; Niţă I
    Med Interne; 1979; 17(2):169-74. PubMed ID: 472639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of clofibrate on fibrinolysis and platelet adhesiveness and aggregation in patients with arteriosclerosis].
    Cajozzo A; Abbadessa V; Carreca I; Perricone R
    Boll Soc Ital Cardiol; 1973; 18(4):361-7. PubMed ID: 4807075
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma protein concentrations in hypertriglyceridaemic subjects. Effect of clofibrate and comparison with normal subjects.
    Ballantyne FC; Morrison BA; Ballantyne D; Dryburgh FJ; Epenetos AA
    Clin Chim Acta; 1978 Jul; 87(1):43-7. PubMed ID: 668144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the effect of heparin and atromide-S on the adhesiveness of platelets in the postinfarction period].
    Kusá O
    Bratisl Lek Listy; 1971 Nov; 56(5):630-6. PubMed ID: 5159587
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate.
    Baldoni E; Egge H; Cuttin S; Murawski U; Gibelli A; Giarola P
    Farmaco Sci; 1973 Sep; 28(9):713-21. PubMed ID: 4749857
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of ICI 55,897 and clofibrate on platelet function and other tests abnormal in atherosclerosis.
    O'Brien JR; Etherington MD; Jamieson S; Sussex J; Shuttleworth RD
    Thromb Haemost; 1978 Aug; 40(1):75-82. PubMed ID: 364763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes.
    Kwaan HC
    Diabetes; 1992 Oct; 41 Suppl 2():32-5. PubMed ID: 1388126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern concepts of the hemostatic and fibrinolytic systems].
    Andreenko GV
    Klin Med (Mosk); 1974 Apr; 52(4):13-23. PubMed ID: 4282102
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet stickiness and serum cholesterol levels after myocardial infarction treated with clofibrate and heparine.
    Kusá O
    Acta Univ Carol Med Monogr; 1972; 53():413-6. PubMed ID: 4670747
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of some serum protein fractions in various clinical forms of diabetes mellitus.
    Cheţa D; Mihalache N; Sântu E; Mincu I
    Med Interne; 1981; 19(1):55-61. PubMed ID: 7233048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of plasma expanders on coagulation and hemostasis: dextran hydroxyethyl starch, and other macromolecules revisited.
    Alexander B
    Prog Clin Biol Res; 1978; 19():293-330. PubMed ID: 78500
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of etofylline clofibrate on experimental thrombosis and platelet function.
    Sim AK; Davies ME; McCraw AP; Metz G
    Arzneimittelforschung; 1980; 30(11b):2042-5. PubMed ID: 7194057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary studies on changes induced by clofibrate in the values of haptoglobin and orosomucoid in arteriosclerotic subjects].
    Cajozzo A; Citarrella P; Malleo C; Perricone R
    Boll Soc Ital Cardiol; 1973; 18(4):368-72. PubMed ID: 4807076
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin and platelets.
    O'Brien JR
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):79-90. PubMed ID: 808394
    [No Abstract]   [Full Text] [Related]  

  • 16. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
    van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in juvenile-onset and maturity-onset diabetes mellitus.
    Sharma SC
    J Clin Pathol; 1981 May; 34(5):501-3. PubMed ID: 7053039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of clofibrate on inflammation-induced alterations in plasma proteins in the rat.
    Powanda MC; Abeles FB; Bostian KA; Fowler JP; Hauer EC
    Biochem J; 1979 Mar; 178(3):633-41. PubMed ID: 88218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on ADP-induced platelet aggregation in normal and diseased groups.
    Yamakido M; Oishi N; Yokoyama M
    Hawaii Med J; 1970; 29(6):446-9. PubMed ID: 5503441
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis.
    O'Brien JR; Etherington MD; Jamieson S; Lawford P; Lincoln SV; Alkjaersig NJ
    Thromb Diath Haemorrh; 1975 Nov; 34(2):483-97. PubMed ID: 53892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.